XinLiu (Liu Xin): Born on February 23rd, 1968, she holds a bachelor's degree and a master's degree in molecular biology from the University of Cologne, with a minor in business administration. He won the Friedrich-friedrich naumann foundation Scholarship and completed his graduation thesis in the Institute of Genetics established by German Nobel Prize winner MaxDelbruck. He used to be the director of enterprise development and M&A in Asia-Pacific region and emerging markets of GSKLondon, and worked in RocheBasel, Switzerland, where he was committed to the global development of new drug business and the leadership responsibilities of M&A, business development and marketing/sales in Lilly Pharmaceutical Company. Currently, he is the managing director of China branch of Great Pacific Capital (GPC), a private equity investment company focusing on medical health and IT in London. He is also a director of Sino-American Aimeijin Pharmaceutical Company.